Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
102
Frequently Asked Questions
What is Market Cap of Aytu BioPharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aytu BioPharma Inc market cap is $14.19M.
What is the 52-week high for Aytu BioPharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aytu BioPharma Inc 52 week high is $2.85 as of September 12, 2025.
What is the 52-week low for Aytu BioPharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aytu BioPharma Inc 52 week low is $0.95 as of September 12, 2025.
What is Aytu BioPharma Inc stock price today?
Aytu BioPharma Inc stock price today is $2.30.
What was Aytu BioPharma Inc stock price yesterday?
Aytu BioPharma Inc stock price yesterday was $2.30.
What is the PE ratio of Aytu BioPharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aytu BioPharma Inc’s P/E ratio is -3.22.
What is the Price-to-Book ratio of Aytu BioPharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aytu BioPharma Inc P/B ratio is 0.4067.
What is the 50-day moving average of Aytu BioPharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aytu BioPharma Inc 50-day moving average is $2.34.
